Forbes Magazine Names Incyte One of the World’s Most Innovative Companies for Third Consecutive Year
August 10 2017 - 8:45AM
Business Wire
Company ranked 6th in 2017 and in Top 10
for Third Year Running
Incyte Corporation (Nasdaq:INCY) today announced it has been
ranked 6th on Forbes magazine’s 2017 list of
the World’s Most Innovative Companies. Incyte, a
biopharmaceutical company focused on the discovery, development and
commercialization of proprietary therapeutics, is advancing an
innovative and diverse portfolio of large and small molecules
comprised of 17 development candidates against 14 different
molecular targets.
“It is an honor to be recognized as one of the World’s Most
Innovative Companies by Forbes year-after-year,” said Hervé
Hoppenot, Incyte’s Chief Executive Officer. “At Incyte, innovation
is in our DNA. We push ourselves every day to be at the forefront
of advancing science as we research and develop treatments that
will positively impact the lives of patients around the world.”
Forbes’ ranking is based on the companies’ “innovation
premium,” and only includes industries that are known to invest in
innovation and businesses that have at least seven years of
financial data and a market value greater than $10
billion.
To view the complete list,
visit http://www.forbes.com/innovative-companies/list/.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based
biopharmaceutical company focused on the discovery, development and
commercialization of proprietary therapeutics. For additional
information on Incyte, please visit the Company’s website at
www.incyte.com.
Follow @Incyte on Twitter
at https://twitter.com/Incyte.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170810005610/en/
Incyte CorporationMediaCatalina Loveman, +1 302 498
6171cloveman@incyte.comorInvestorsMichael Booth, DPhil, +1
302 498 5914mbooth@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Sep 2023 to Sep 2024